Congenital myasthenic syndromes: Recent advances

Archives of Neurology

Volumn 56, Issue 2, 1999, Pages 163-167

  Engel, Andrew G ^a,b   Ohno, Kinji ^a   Sine, Steven M ^b  

^a Neuromuscular Disease Laboratory   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR;

CHANNEL GATING; ENZYME SUBUNIT; HUMAN; MISSENSE MUTATION; MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR DENSITY; REVIEW; SYNAPTIC POTENTIAL;

HUMANS; MUTATION; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC; SYNAPSES; SYNDROME;

EID: 0033027785     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.2.163     Document Type: Review

References (32)

1. Engel AG. Myasthenic syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology: Basic and Clinical. 2nd ed. New York, NY: McGraw-Hill; 1994:1798-1835.
2. Milone M, Hutchinson DO, Engel AG. Patch-clamp analysis of the properties of acetylcholine receptor channels at the normal human endplate. Muscle Nerve. 1994;17:1364-1369.
3. Ohno K, Hutchinson DO, Milone M, et al. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ∈ subunit. Proc Natl Acad Sci U S A. 1995;92: 758-762.
4. Sine SM, Ohno K, Bouzat C, et al. Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron. 1995;15:229-239.
5. Engel AG, Ohno K, Milone M, et al. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet. 1996;5:1217-1227.
6. Milone M, Wang H-L, Ohno K, et al. Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor alpha subunit J Neurosci. 1997; 17:5651-5665.
7. Ohno K, Quiram P, Milone M, et al. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor ∈ subunit gene: identification and functional characterization of six new mutations. Hum Mol Genet. 1997;6:753-766.
8. Ohno K, Wang H-L, Milone M, et al. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ∈ subunit. Neuron. 1996;17:157-170.
9. Ohno K, Engel AG, Milone M, et al. A congenital myasthenic syndrome with severe acetylcholine receptor deficiency caused by heteroallelic frameshifting mutations in the epsilon subunit [abstract]. Neurology. 1995;45(suppl 4):A283.
10. Milone M, Ohno K, Pruitt JN, et al. Congenital myasthenic syndrome due to frameshifting acetylcholine receptor epsilon subunit mutation [abstract]. Soc Neurosci Abstr. 1996;22:1942.
11. Ohno K, Fukudome T, Nakano S, et al. Mutational analysis in a congenital myasthenic syndrome reveals a novel acetylcholine receptor epsilon subunit mutation [abstract]. Soc Neurosci Abstr. 1996;22:234.
12. Engel AG, Ohno K, Bouzat C, Sine SM, Griggs RG. End-plate acetylcholine receptor deficiency due to nonsense mutations in the ∈ subunit. Ann Neurol. 1996; 40:810-817.
13. Milone M, Wang H-L, Ohno K, et al. Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor ∈ subunit. Neuron. 1998;20:575-588.
14. Ohno K, Anlar B, Özdirim E, et al. Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor. Ann Neurol. 1998;44:234-241.
15. Soreq H, Ben-Azis R, Prody CA, et al. Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G+C-rich attenuating structure. Proc Natl Acad Sci U S A. 1990;87:9688-9692.
16. Li Y, Camp S, Rachinsky TL, Getman D, Taylor P, Gene structure of mammalian acetylcholinesterase: alternative exons dictate tissue specific expression. J Biol Chem. 1991;266:23083-23090.
17. Ohno K, Brengman JM, Tsujino A, Engel AG. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (CoIQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A. 1998;95:9654-9659.
18. Croxen R, Newland C, Beeson D, et al. Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet. 1997;6:767-773.
19. Croxen R, Beeson D, Vincent A, Newsom-Davis J. Congenital myasthenic syndrome with a single nucleotide deletion at the intron/exon boundary in exon 12 of the gene encoding the acetylcholine receptor ∈ subunit [abstract]. Ann Neurol. 1996;40:513.
20. Gomez CM, Maselli R, Gammack J, et al. A beta-subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome. Ann Neurol. 1996; 39:712-723.
21. Ohno K, Hutchinson DO, Milone M, et al. Molecular genetic basis of a slow channel syndrome [abstract]. Muscle Nerve. 1995;18:463.
22. Wang H-L, Auerbach A, Bren N, et al. Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol. 1997;109:757-766.
23. Ohno K, Milone M, Brengman JM, et al. Slow-channel congenital myasthenic syndrome caused by a novel mutation in the acetylcholine receptor ∈ subunit [abstract]. Neurology. 1998;50:A432.
24. Fukudome T, Ohno K, Brengman JM, Engel AG. Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport. 1998; 9:1907-1911.
25. Harper CM, Engel AG. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Ann Neurol. 1998;43:480-484.
26. Uchitel O, Engel AG, Walls TJ, et al. Congenital myasthenic syndromes, II: a syndrome attributed to abnormal interaction of acetylcholine with its receptor. Muscle Nerve. 1993;16:1293-1301.
27. Milone M, Ohno K, Brengman JM, et al. Low-affinity fast-channel congenital myasthenic syndrome caused by new missense mutations in the acetylcholine receptor α subunit [abstract]. Neurology. 1998;50:A432-A433.
28. Middleton LF, Ohno K, Christodoulou K, et al. Congenital myasthenic syndromes linked to chromosome 17p are caused by defects in acetylcholine receptor ∈ subunit gene [abstract]. Neurology. 1998;50:A432.
29. Krejci E, Coussen F, Duval N, et al. Primary structure of a collagenic tail peptide of Torpedo acetylcholinesterase: co-expression with catalytic subunit induces the production of collagen-tailed forms in transfected cells EMBO J. 1991;10:1285-1293.
30. Krejci E, Thomine S, Boschetti N, et al. The mammalian gene of acetylcholinesterase-associated collagen. J Biol Chem. 1997;272:22840-22847.
31. Engel AG, Lambert EH, Gomez MR. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol. 1977;1:315-330.
32. Ohno K, Brengman JM, Milone M, et al. Congenital endplate acetylcholinesterase deficiency: novel missense and null mutations in the collagen-like tail subunit of the asymmetric enzyme [abstract]. Am J Hum Genet. 1998;63:A377.